Faham A, Prinderre P, Farah N, Eichler K D, Kalantzis G, Joachim J
Laboratoire de Pharmacie Galénique, Faculty of Pharmacy, Marseille, France.
Drug Dev Ind Pharm. 2000 Feb;26(2):167-76. doi: 10.1081/ddc-100100341.
The aim of this work was to study the influence of theophylline granule size and the percentage of Compritol 888 Ato on in vitro drug release from granules and tablets. The granules were coated in a fluidized bed apparatus. The dissolution profiles of these granules differed from those of granules coated with classical agents, and there were also differences between the various sieve fractions studied. Drug release was characterized by a rapid-release phase, followed by a slow-release phase. Results indicate that theophylline release can be controlled by controlling granule size. Inspection of the appearance of the tablets at the end of the dissolution test revealed that all tablets containing Compritol 888 Ato remained intact. This indicated that the Compritol 888 Ato used in the tablet formulation created an inert matrix through which the drug diffused. It was found that the Higuchi relationship of linear square root of time was the best model to describe the release kinetics of the drug from tablets. This also confirmed that a matrix diffusion-controlled mechanism was operative. Given the difference between the dissolution profiles of the granules and the tablets, it was concluded that this matrix is formed during compression.
本研究的目的是考察茶碱颗粒大小和Compritol 888 Ato的比例对颗粒剂和片剂体外药物释放的影响。颗粒剂在流化床设备中进行包衣。这些颗粒剂的溶出曲线与用传统包衣剂包衣的颗粒剂不同,在所研究的不同筛分级分之间也存在差异。药物释放的特征是一个快速释放阶段,随后是一个缓慢释放阶段。结果表明,茶碱释放可通过控制颗粒大小来控制。在溶出试验结束时对片剂外观的检查表明,所有含有Compritol 888 Ato的片剂均保持完整。这表明片剂配方中使用的Compritol 888 Ato形成了一个惰性基质,药物通过该基质扩散。研究发现,时间平方根的Higuchi关系是描述药物从片剂中释放动力学的最佳模型。这也证实了基质扩散控制机制起作用。鉴于颗粒剂和片剂溶出曲线的差异,得出结论,这种基质是在压片过程中形成的。